Cargando…
Measurement of Patient-Derived Glioblastoma Cell Response to Temozolomide Using Fluorescence Lifetime Imaging of NAD(P)H
Personalized strategies in glioblastoma treatment are highly necessary. One of the possible approaches is drug screening using patient-derived tumor cells. However, this requires reliable methods for assessment of the response of tumor cells to treatment. Fluorescence lifetime imaging microscopy (FL...
Autores principales: | Yuzhakova, Diana V., Sachkova, Daria A., Shirmanova, Marina V., Mozherov, Artem M., Izosimova, Anna V., Zolotova, Anna S., Yashin, Konstantin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301219/ https://www.ncbi.nlm.nih.gov/pubmed/37375743 http://dx.doi.org/10.3390/ph16060796 |
Ejemplares similares
-
FLIM of NAD(P)H in Lymphatic Nodes Resolves T-Cell Immune Response to the Tumor
por: Izosimova, Anna V., et al.
Publicado: (2022) -
Development of a 3D Tumor Spheroid Model from the Patient’s Glioblastoma Cells and Its Study by Metabolic Fluorescence Lifetime Imaging
por: Yuzhakova, D.V., et al.
Publicado: (2023) -
Highly Invasive Fluorescent/Bioluminescent Patient-Derived Orthotopic Model of Glioblastoma in Mice
por: Yuzhakova, Diana, et al.
Publicado: (2022) -
Corrigendum: Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice
por: Yuzhakova, Diana, et al.
Publicado: (2022) -
Label-Free Macroscopic Fluorescence Lifetime Imaging of Brain Tumors
por: Lukina, Maria, et al.
Publicado: (2021)